Stem Cell Treatment for MS Improves Immune System and Extends Remission
A new report shows that stem cell transplants might soon offer multiple sclerosis (MS) patients an effective way to stave off relapses and improve their overall neurologic condition.
Stroke Drug May Halt Progression of Alzheimer’s
Scientists at the University of South Australia and colleagues from Third Military Medical University in Chongqing, China, have found that the drug Edaravone alleviates Alzheimer’s disease pathologies at multiple levels and improves learning and memory functions in mice.
CMS Expands Coverage of HYQVIA for PI Patients to In-Home Use
The Centers for Medicare and Medicaid Services (CMS) has expanded coverage to include in-home use of HYQVIA(immune globulin infusion 10 percent [human] with recombinant humanhyaluronidase) to treat primary immunodeficiency patients.
Recombinant IVIG Granted Orphan Drug Designation for CIDP
Pfizer (a licensee of Gliknik Inc.) has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for its recombinant intravenous immune globulin (IVIG)-mimetic drug
GL-2045 to treat chronic inflammatory demyelinating polyneuropathy (CIDP).
FDA Accepts BLA for CSL’s rIX-FP for Hemophilia B Patients
CSL Behring’s Biologics License Application for the marketing authorization of its long-acting fusion protein linking recombinant coagulation factor IX with recombinant albumin, rIX-FP, has been accepted for review by the U.S.
Octapharma USA Launches Co-Pay Program for Wilate
Octapharma USA has launched the Octapharma Co-Pay Assistance Program available to von Willebrand’s disease patients who are currently receiving Wilate or have a prescription to begin therapy.
HHS Contracts with BioCryst to Develop New Ebola Drug
The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) has awarded approximately $12 million to BioCryst Pharmaceuticals for the advanced development of a promising experimental drug for Ebola.
Novo Nordisk Launches Novoeight for Hemophilia A in the U.S.
Novo Nordisk has launched Novoeight (antihemophilic factor [recombinant]) in the U.S. for people living with hemophilia A.
New Anti-Aging Drug Could Improve Seniors’ Immune Systems
A new experimental drug could boost the immune system in older adults by as much as 20 percent, as well as help them to delay other aging effects.
Octapharma USA Launches Co-Pay Program for Wilate
Octapharma USA has launched the Octapharma Co-Pay AssistanceProgram available to von Willebrand’s disease patients who are currently receiving Wilate (von Willebrand factor/coagulation factor VIII complex[human]) or have a prescription to begin therapy.